Protagonist Therapeutics, Inc
- Stock
- Ticker PTGX
- Nasdaq
Performance, volatility and drawdowns of Protagonist Therapeutics, Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $48,175. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −85.8% in 06/2022, measured from the peak in 09/2021. It took 42 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 171 | 28 | 5.5 | 4.7 | 7.4 | 56 | 213 | 274 |
| Gross profit | – | – | – | – | – | – | – | 273 |
| Operating income | 127 | -19 | -42 | -46 | -50 | -3.6 | 159 | 218 |
| EBITDA | 127 | -19 | -42 | -46 | -50 | -3.2 | 159 | 219 |
| Net income | 132 | -12 | -35 | -39 | -44 | 3.8 | 163 | 220 |
| Earnings per share | 2.01 | -0.19 | -0.55 | -0.62 | -0.70 | 0.05 | 2.29 | 3.07 |
| Balance sheet | ||||||||
| Total assets | 745 | 742 | 718 | 702 | 668 | 697 | 886 | 1,147 |
| Liabilities | 69 | 53 | 50 | 56 | 53 | 42 | 44 | 62 |
| Equity | 675 | 689 | 668 | 645 | 615 | 655 | 842 | 1,085 |
| Cash | 97 | 140 | 169 | 114 | 128 | 194 | 420 | 498 |
| Cash flow | ||||||||
| Operating cash flow | -29 | 125 | -29 | -1.9 | -37 | -49 | 219 | -23 |
| Capital expenditure | -0.3 | -0.5 | -0.8 | -0.1 | -0.1 | -0.2 | -0.2 | -0.2 |
| Free cash flow | -29 | 125 | -30 | -2.0 | -37 | -49 | 219 | -23 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +186.0%, weakest 2022 at −68.1%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | $3.07 |
| 5 Aug 2026 | $2.29 |
| 5 May 2026 | $0.05 |
| 25 Feb 2026 | −$0.70 |
| 6 Nov 2025 | −$0.62 |
| 6 Aug 2025 | −$0.55 |
| 6 May 2025 | −$0.19 |
| 21 Feb 2025 | $2.01 |
| 7 Nov 2024 | −$0.54 |
| 6 Aug 2024 | −$0.50 |
| 7 May 2024 | $3.26 |
| 27 Feb 2024 | $0.52 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €7.2bn
- Market cap in trading currency
- $7.92bn
- Enterprise value
- $7.12bn
- P/E
- 25.8
- P/S
- 14.36
- P/B
- 7.30
- EV/Sales
- 12.91
- EV/EBITDA
- 21.9
- Earnings yield
- 3.9%
- FCF yield
- 1.4%
Results (last four quarters)
- Revenue
- $552m
- Gross profit
- –
- EBITDA
- $325m
- Net income
- $342m
- Earnings per share
- $4.71
- Revenue per share
- $8.45
- Revenue growth
- +5,723.6%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- 58.6%
- Net margin
- 62.0%
- Return on equity
- 39.6%
- Return on assets
- 29.9%
Balance sheet and cash flow
- Cash
- $800m
- Cash per share
- $12.26
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 19.85
- Book value per share
- $16.62
- Operating cash flow
- $110m
- Free cash flow
- $109m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 65.3m
- Volume
- 600,711
- Avg. volume 3 months
- 670,345
- Relative volume
- 0.9
Price and technicals
- Price
- $121.40
- 1 day
- −2.1%
- 52-week high
- $158.62
- 52-week low
- $79.73
- Distance to 52-week high
- −23.5%
- Distance to 52-week low
- +52.3%
- Distance to 50-day line
- −12.1%
- Distance to 200-day line
- +0.9%
- RSI (14)
- 32
- Volatility 1M
- 37.3%
Performance
- 1 week
- −7.3%
- 1 month
- −13.0%
- 3 months
- −21.5%
- 6 months
- +22.4%
- YTD
- +39.0%
- 1 year
- +42.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has PTGX performed since 11/2016?
$10,000 grew to $48,175 by 20 Nov 2026, which is +17.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is PTGX?
Volatility was 83.0% per year, measured on monthly returns. The largest decline from a peak was −85.8%, with the low in 06/2022.
How does PTGX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, PTGX returned +17.0% at 83.0%. The correlation of monthly returns was 0.31; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.